About FlexGRIP
FlexGRIP is a Healthcare company based in Diepenbeek (Belgium) founded in 2011 by Alexander Van Damme and David De Munter. It operates as a catheter cushions and stabilisation devices are provided for patient safety. FlexGRIP has raised $11 million across 1 funding round from investors including SFPIM, White Fund and F3 Finance. The company has 2 employees. Its chief executive is Alexander Van Damme. FlexGRIP offers products and services including FlexGRIP Neonates, FlexGRIP Pediatrics, and FlexGRIP Adult. Its focus areas include Life Sciences, Drug Delivery and Accessories. Its legal entity is Bedal NV. Its competitors include EyeGate, SiVEC Biotechnologies, PionEar Technologies, Diavibe and Yukon Medical and 1 more; 3 of its 6 listed competitors have raised funding.
Company details
FlexGRIP was founded in 2011 in Diepenbeek, Belgium, as a provider in the medical device sector focused on vascular access solutions. A range of FlexGrip products is offered, designed to minimize risks of catheter dislodgement and infection while supporting patient comfort and mobility. Operations center on developing and distributing these stabilisation devices across healthcare settings in Europe.
- Headquarters Diepenbeek, Belgium
- Employees 2
- Founders Alexander Van Damme, David De Munter
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website flex-grip.com
- Social LinkedIn
- Legal Name Bedal Nv
- Annual Revenue$519.78 K (USD)125as on Dec 31, 2018
- Net Profit-$519.77 K (USD)-125as on Dec 31, 2018
- Total Equity Funding$11M (USD)
in 1 rounds
- Latest Funding Round$11M (USD), Series A
Jun 2024
- InvestorsSFPIM
& 3 more
- Employee Count2
Products & Services of FlexGRIP
FlexGRIP offers a comprehensive portfolio of products and services, including FlexGRIP Neonates, FlexGRIP Pediatrics, and FlexGRIP Adult.
Device for securing catheters in neonates to prevent dislodgment and reduce skin irritation.
Hydrocolloid adhesive system for pediatric catheter securement to avoid complications.
Acrylic adhesive for adult catheters, ensuring firm hold without skin prep.
Funding Insights of FlexGRIP
FlexGRIP has successfully raised a total of $11M through 1 strategic funding round. The most recent funding activity was a Series A round of $11 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11M
- Total Rounds 1
- Last Round Series A — $11M
- First Round $11M
(Jun 2024)
- Investors Count 4
All 1 funding rounds of FlexGRIP with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $11M | Series A | – | White Fund, F3 Finance | – |
4 investors in total: 4 institutional.
Investors in FlexGRIP
FlexGRIP has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include SFPIM, White Fund and F3 Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A Belgian venture capital fund focused on medtech innovations is operated. | 2019 | whitefund.be | Liège, Belgium | |
- | – | f3finance.be | - | |
LRM is engaged in providing risk capital and smart money to businesses in Limburg. | – | lrm.be | Hasselt, Belgium | |
Sovereign wealth fund focused on life sciences, finance, energy, impact investment, real estate, and multiple sectors | 2006 | sfpim.be | Brussels, Belgium |
Investor details for FlexGRIP
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of FlexGRIP
3 people are tracked at FlexGRIP (3 in leadership); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Alexander Van Damme | Co-Founder & Co-CEO | Leadership |
David De Munter | Co-Founder | Leadership |
Steve Bierman | Co-CEO | Leadership |
Complete people profiles for FlexGRIP
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of FlexGRIP
2 dated milestones of FlexGRIP across 13 years, from founding to its latest funding, stage changes and deals.
- Founded FlexGRIP is founded.
- Funding First funding round of $11.0M.
Competitors of FlexGRIP
FlexGRIP has 6 listed competitors in our database, 3 of them funded. They include EyeGate, SiVEC Biotechnologies, PionEar Technologies, Diavibe and Yukon Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eyegatepharma.com | 1998 | Waltham, United States | $44.47M | 12 | Therapeutics and drug delivery systems for eye diseases are developed. | |
| sivecbiotechnologies.com | 2016 | Fort Collins, United States | $3.3M | – | Antiviral products are developed using patent-pending technology for disease prevention. | |
| pionear-tech.com | 2018 | Boston, United States | $50,000 | – | It serves as a limited information available. | |
| diavibe.com | 2010 | Providence, United States | – | – | Provides drug-free topical anesthetic solutions for effective pain relief. | |
| yukonmedical.com | 2008 | Durham, United States | – | 13 | Develops devices for safe medication preparation, vial access, and sample collection. | |
| therasonic.fr | 2023 | Paris, France | – | – | Develops medical devices for non-invasive brain drug delivery and barrier disruption. |
Detailed competitors of FlexGRIP
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as FlexGRIP (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Flexgrip
Complete news archive for FlexGRIP
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FlexGRIP
FlexGRIP was founded in 2011 and raised its 1st funding round 13 years after it was founded.
FlexGRIP is headquartered in Diepenbeek, Belgium. It is registered at Diepenbeek, Limburg, Belgium.
Alexander Van Damme is the current CEO of FlexGRIP. They have also founded this company.
FlexGRIP is a funded company, having raised a total of $11M across 1 funding round to date. The company's 1st funding round was a Series A of $11M, raised on Jun 2024.
FlexGRIP has 2 employees.
Annual revenue of FlexGRIP is $519.78K as on Dec 31, 2018.
FlexGRIP was founded in 2011 in Diepenbeek, Belgium, as a provider in the medical device sector focused on vascular access solutions. A range of FlexGrip products is offered, designed to minimize risks of catheter dislodgement and infection while supporting patient comfort and mobility. Operations center on developing and distributing these stabilisation devices across healthcare settings in Europe.
FlexGRIP's top competitors include EyeGate, SiVEC Biotechnologies and PionEar Technologies.
FlexGRIP offers FlexGRIP Neonates, FlexGRIP Pediatrics, and FlexGRIP Adult.
FlexGRIP has 4 investors. Key investors include SFPIM, White Fund, F3 Finance, and LRM.
FlexGRIP operates through Bedal Nv.